Sep 1, 2026

Description: Featuring a slide presentation and related discussion from Prof Ticiana Leal, including the following topics:

·      Incidence, pathophysiology and clinical presentation (0:00)

·      Diagnostic challenges and evaluation process (3:37)

·      Treatment modalities and therapeutic options (10:01)

·

Sep 1, 2026

Featuring an interview with Prof Ticiana Leal, including the following topics:

• Pathophysiology and clinical signs and symptoms (0:00)
• Screening and/or diagnostic approaches (5:45)
• Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
• Key clinical trial data for...

Aug 7, 2026

Featuring perspectives from Dr Anne Chiang, Dr Apar Kishor Ganti, Dr Luis Paz-Ares and Dr Misty Dawn Shields, moderated by Dr Shields, including the following topics:

• Introduction (0:00)
• Optimizing First-Line and Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (SCLC) — Dr Shields (2:17)
• Management of...

Aug 4, 2026

Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics:

• Introduction: Relative Impact of Targeted Treatment (0:00)
• HER2 Alterations (8:04)
• KRAS Mutations (24:25)
• MET Overexpression (30:34)
• ALK Fusions (32:34)
• ROS1 Fusions (42:36)
• RET Fusions (52:00)

CME information and...

Aug 3, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | Faculty Presentation 2: Therapeutic Approaches Targeting ALK, ROS1 and RET — Maurice Pérol, MD 

CME information and select...